PHIBRO ANIMAL HEALTH CORPORATION CLASS A

PHIBRO ANIMAL HEALTH CORPORATION CLASS A (PAHC) is currently trading at $46.60. The stock has a 52-week range of $16.16 to $56.30 and a market capitalization of $1.89B.

PHIBRO ANIMAL HEALTH CORPORATION CLASS A has a P/E ratio of 20.6 (forward P/E: 13.9), a dividend yield of 1.00%, and 1-year performance of +104.6%. 0 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.

There have been 123 insider transactions for PAHC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.

PHIBRO ANIMAL HEALTH CORPORATION CLASS A (PAHC) has returned +104.6% over the past 12 months. The stock traded between $16.16 and $56.30 during this period, and is currently at $46.60.

0 tracked hedge funds currently hold PAHC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.

PHIBRO ANIMAL HEALTH CORPORATION CLASS A (PAHC) has a market capitalization of $1.89B. The trailing P/E ratio is 20.6 and forward P/E is 13.9. The stock is classified in the Healthcare sector.

PHIBRO ANIMAL HEALTH CORPORATION CLASS A reported revenue of $1.46B with net income of $92.09M and a profit margin of 0.06%. The stock has a beta of 0.71.

PHIBRO ANIMAL HEALTH CORPORATION CLASS A (PAHC) operates in the Healthcare sector. It is held by 0 tracked hedge funds. See the ownership table above for the complete list.